TW200735880A - Medicinal compositions for preventing or treating heart failure - Google Patents

Medicinal compositions for preventing or treating heart failure

Info

Publication number
TW200735880A
TW200735880A TW096102418A TW96102418A TW200735880A TW 200735880 A TW200735880 A TW 200735880A TW 096102418 A TW096102418 A TW 096102418A TW 96102418 A TW96102418 A TW 96102418A TW 200735880 A TW200735880 A TW 200735880A
Authority
TW
Taiwan
Prior art keywords
preventing
heart failure
treating heart
medicinal compositions
present
Prior art date
Application number
TW096102418A
Other languages
Chinese (zh)
Inventor
Masanori Izumi
Keiko Matsumura
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of TW200735880A publication Critical patent/TW200735880A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)

Abstract

The subject of the present invention is to provide a medicinal composition for preventing or treating heart failure. The present invention provides a medicinal composition, which contains, as the active component, a carbohydrase inhibitor.
TW096102418A 2006-01-27 2007-01-23 Medicinal compositions for preventing or treating heart failure TW200735880A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006018374 2006-01-27

Publications (1)

Publication Number Publication Date
TW200735880A true TW200735880A (en) 2007-10-01

Family

ID=38309234

Family Applications (1)

Application Number Title Priority Date Filing Date
TW096102418A TW200735880A (en) 2006-01-27 2007-01-23 Medicinal compositions for preventing or treating heart failure

Country Status (4)

Country Link
JP (1) JPWO2007086446A1 (en)
CN (1) CN101370520A (en)
TW (1) TW200735880A (en)
WO (1) WO2007086446A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101904920B1 (en) * 2012-05-18 2018-10-08 (주)아모레퍼시픽 Composition for skin whitening containg voglibose

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4090013B2 (en) * 2000-12-26 2008-05-28 第一三共株式会社 Pharmaceutical composition containing diuretic and insulin resistance improving agent
ATE478884T1 (en) * 2003-01-30 2010-09-15 Daiichi Sankyo Co Ltd OLIGOSACCHARIDE DERIVATIVE
TW200608967A (en) * 2004-07-29 2006-03-16 Sankyo Co Pharmaceutical compositions containing with diabetic agent

Also Published As

Publication number Publication date
JPWO2007086446A1 (en) 2009-06-18
CN101370520A (en) 2009-02-18
WO2007086446A1 (en) 2007-08-02

Similar Documents

Publication Publication Date Title
MA33803B1 (en) BENZODIAZEPINE BROMODOMAINE INHIBITOR
GEP20135724B (en) Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for treatment or prevention of diabetes
MX2008012490A (en) Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes.
WO2008033562A3 (en) Kinase inhibitor compounds
MY148634A (en) Pyridazinone derivatives
PH12013500913A1 (en) Substituted-quinoxaline-type-piperidine compounds and the uses thereof
PT1984357E (en) 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
MY146969A (en) Dpp iv inhibitor formulations
MX2012002633A (en) Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes.
NO20092569L (en) Inhibitors of Akt activity
WO2009152356A3 (en) Compounds and compositions useful for the treatment of malaria
UA94749C2 (en) Benzimidazole modulators of vr1
MX2009000657A (en) Compositions and methods for the treatment of mucositis.
GEP20156309B (en) Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
UA103930C2 (en) Normal;heading 1;heading 2;heading 3;COMPOUNDS AND COMPOSITION FOR THE TREATMENT OF PARASITIC DISEASES
EA201270590A1 (en) ACTIVE INHIBITORS
MY153948A (en) Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof
ZA200806778B (en) N-Hydroxyacrylamide compounds
EA201200968A1 (en) USE OF TRANS-CLOMIPHENE FOR THE PREVENTION OR TREATMENT OF DIABETES TYPE 2 IN MEN
MY152685A (en) Imidazopyridazines as par1 inhibitors, production thereof, and use thereof as medicaments
MY152040A (en) Triazolopyridazines as par1 inhibitors, production thereof, and use as medicaments
MX2009012079A (en) Condensed heterocyclic compounds as inhibitors of protein kinases.
TW200735880A (en) Medicinal compositions for preventing or treating heart failure
TNSN08242A1 (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
MX2009010164A (en) Method for treating cb2 receptor mediated pain.